Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness

Conditions: Severe Aplastic Anemia; Platelet Transfusion Refractoriness Interventions: Drug: Rituximab Sponsors: Institute of Hematology& Blood Diseases Hospital, China Recruiting

https://clinicaltrials.gov/study/NCT06254560

Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials